Freshly Printed - allow 10 days lead
Couldn't load pickup availability
Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3
Translational and Clinical Outcomes
Presents an up-to-date overview of all aspects of the clinical assessment, management and precision medicine for hepatocellular carcinoma
Ganji Purnachandra Nagaraju (Edited by), Sarfraz Ahmad (Edited by)
9780323992831, Elsevier Science
Hardback, published 21 April 2022
468 pages
23.5 x 19 x 2.9 cm, 1.13 kg
Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma: Translational and Clinical Outcomes, Volume Three provides comprehensive information about ongoing research and clinical data on liver cancer. The book presents detailed descriptions about diagnostics and therapeutic options for easy understanding, with a focus on precision medicine approaches to improve treatment outcomes. This updated volume discusses topics such as clinical and safety assessment of HCC patients, liver transplantation as a therapeutic option, immunotherapy interventions, and image-based surveillance. In addition, it discusses immunohistology of HCC-enabled precision medicine and artificial intelligence for hepatocellular carcinomas. This is a valuable resource for cancer researchers, oncologists, graduate students, hepathologists and members of biomedical research who need to understand more about liver cancer to apply in their research work or clinical setting.
1. Clinical and safety assessment of the HCC patients2. Liver transplantation for HCC therapy3. Clinical trials for HCC in the diagnosis and therapy: An international perspective4. Recent advancements in immunotherapy interventions for the management of HCC5. Role of genetic insights and tumor microenvironment in HCC: New opportunities for gene therapy6. An Update on the treatment of hepatocellular carcinoma7. An update of image-based surveillance in HCC8. Meta-analysis of PD-1/PD-L1 inhibitors in advanced HCC9. Towards a personalized medicine approach for the treatment of HCC10. Precision medicine in the theranostics of HCC11. Immunohistology of HCC-enabled precision medicine12. Artificial Intelligence and Precision Medicine for HCC13. Genomics-Enabled Precision Medicine for HCC
Subject Areas: Enterprise software [UFL], Medical bioinformatics [MBF]
